Fundraising FoxEpiVax Oncology
Providence, US · Founded 2017 · Delaware corporation
Find your way into EpiVax Oncology
Sign up to see every warm intro you have to EpiVax Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EpiVax Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EpiVax Oncology was founded in 2017 by Anne De Groot.
AD
Anne De GrootFounder
WM
William MartinNamed on SEC filing
GB
Gad BerdugoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 4 rounds · 2017–2020
▶$425KraisedFeb 2021 · 6 investors · BiotechnologyRule 506(b)
▶$425KraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LipkinDirector
- Daniel AdamsDirector
- Clifford GrimmExecutive Officer
- William MartinExecutive Officer, Director
- Anne De GrootExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $425K
- Minimum investment
- $1
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$369.9KraisedFeb 2021 · 16 investors · BiotechnologyRule 506(b)
▶$369.9KraisedFeb 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LipkinDirector
- Clifford GrimmExecutive Officer
- Anne De GrootExecutive Officer, Director
- William MartinExecutive Officer, Director
- Daniel AdamsDirector
- Offering amount
- $369.9K
- Amount sold
- $369.9K
- Minimum investment
- $1
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$375KraisedOct 2019 · 5 investors · BiotechnologyRule 506(b)
▶$375KraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anne De GrootExecutive Officer, Director
- Daniel AdamsDirector
- Gad BerdugoExecutive Officer, Director
- William MartinExecutive Officer
- Clifford GrimmExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $375K
- Minimum investment
- $1
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.4MraisedDec 2018 · 14 investors · BiotechnologyRule 506(b)
▶$1.4MraisedDec 2018 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William MartinExecutive Officer, Director
- Gad BerdugoExecutive Officer
- Anne De GrootExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- Minimum investment
- $25K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded EpiVax Oncology?
- EpiVax Oncology was founded by Anne De Groot in 2017.
- How much funding has EpiVax Oncology raised?
- EpiVax Oncology has disclosed $2.6M raised across 4 rounds.
- Where is EpiVax Oncology headquartered?
- EpiVax Oncology is headquartered in Providence, US.